denkapparat Operations’s BioNTech BNTX Stock Holding History

denkapparat Operations’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,670	Closed	-$415K	–	388
2026 Q1	$415K	Buy	+4,670	New	+$480K	0.17%	218

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

denkapparat Operations's BNTX Position: Q2 2026 in Review

denkapparat Operations sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 4,670 shares — an estimated $415K sold.

denkapparat Operations first reported a position in BNTX in Q1 2026 and held it in 1 quarter. The position peaked at $415K in Q1 2026. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

denkapparat Operations reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
denkapparat Operations sold 4,670 BioNTech shares in Q2 2026, an estimated $415K.
denkapparat Operations first reported a position in BioNTech in Q1 2026 and held it in 1 quarter.
denkapparat Operations's BioNTech position peaked at $415K in Q1 2026.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.